Suivre
Mattia Vitale
Mattia Vitale
BiVictriX Therapeutics Ltd
Adresse e-mail validée de bivictrix.com - Page d'accueil
Titre
Citée par
Citée par
Année
Role of OSCAR signaling in osteoclastogenesis and bone disease
IR Nedeva, M Vitale, A Elson, JA Hoyland, J Bella
Frontiers in cell and developmental biology 9, 641162, 2021
512021
Hydroxyapatite-decorated Fmoc-hydrogel as a bone-mimicking substrate for osteoclast differentiation and culture
M Vitale, C Ligorio, B McAvan, NW Hodson, C Allan, SM Richardson, ...
Acta Biomaterialia 138, 144-154, 2022
302022
miR-494.3 p expression in synovial sarcoma: Role of CXCR4 as a potential target gene
L Pazzaglia, S Pollino, M Vitale, E Bientinesi, S Benini, C Ferrari, ...
International Journal of Oncology 54 (1), 361-369, 2018
132018
Incorporation of natural and recombinant collagen proteins within Fmoc-based self-assembling peptide hydrogels
M Vitale, C Ligorio, IP Smith, SM Richardson, JA Hoyland, J Bella
Gels 8 (5), 254, 2022
72022
Collagen-like Osteoclast-Associated Receptor (OSCAR)-Binding Motifs Show a Co-Stimulatory Effect on Osteoclastogenesis in a Peptide Hydrogel System
M Vitale, C Ligorio, SM Richardson, JA Hoyland, J Bella
International Journal of Molecular Sciences 25 (1), 445, 2023
22023
Customised hydrogel matrices for osteoclast differentiation and culture
M Vitale
PQDT-UK & Ireland, 2022
2022
Engineered recombinant collagens as substrates for cell adhesion
JB M Vitale, JD Humphries, C Shaw, L Dean, I BarinagaRementeria, S ...
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 100 (4), A42-A43, 2019
2019
miRNA expression as potential biomarker for synovial sarcoma
L Pazzaglia, S Pollino, M Vitale, A Conti, P Picci, MS Benassi
Cancer Research 77 (13_Supplement), 2534-2534, 2017
2017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–8